Application of image-derived and venous input functions in major depression using [carbonyl-11C]WAY-100635

Nuclear Medicine and Biology

Volumn 40, Issue 3, 2013, Pages 371-377

  Hahn, Andreas ^a   Nics, Lukas ^a   Baldinger, Pia ^a   Wadsak, Wolfgang ^a   Savli, Markus ^a   Kraus, Christoph ^a   Birkfellner, Wolfgang ^b   Ungersboeck, Johanna ^a   Haeusler, Daniela ^a   Mitterhauser, Markus ^a   Karanikas, Georgios ^a   Kasper, Siegfried ^a   Frey, Richard ^a   Lanzenberger, Rupert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

Author keywords

Depression; Electroconvulsive therapy; Image derived input function; Serotonin 1A receptor; TrueX image reconstruction

Indexed keywords

CARBON CARBONYL N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE C 11; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RADIOPHARMACEUTICAL AGENT; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ALGORITHM; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; IMAGE DERIVED INPUT FUNCTION; IMAGE RECONSTRUCTION; LIGAND BINDING; LONGITUDINAL STUDY; MAJOR DEPRESSION; MALE; MATHEMATICAL MODEL; MULTILINEAR REFERENCE TISSUE MODEL; ORDERED SUBSET EXPECTATION MAXIMIZATION WITH SUBSEQUENT PARTIAL VOLUME CORRECTION; POINT SPREAD FUNCTION; POSITRON EMISSION TOMOGRAPHY; RECEPTOR BINDING; TWO TISSUE COMPARTMENT MODEL;

ALGORITHMS; CARBON RADIOISOTOPES; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; VEINS;

EID: 84875261544     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.12.011     Document Type: Article

References (43)

1. Zanotti-Fregonara P., Chen K., Liow J.S., Fujita M., Innis R.B. Image-derived input function for brain PET studies: many challenges and few opportunities. J Cereb Blood Flow Metab 2011, 31:1986-1998.
2. Wang W., Lee N.Y., Georgi J.C., Narayanan M., Guillem J., Schoder H., et al. Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer. J Nucl Med 2010, 51:37-45.
3. Schiepers C., Chen W., Cloughesy T., Dahlbom M., Huang S.C. 18F-FDOPA kinetics in brain tumors. J Nucl Med 2007, 48:1651-1661.
4. Backes H., Ullrich R., Neumaier B., Kracht L., Wienhard K., Jacobs A.H. Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma. Eur J Nucl Med Mol Imaging 2009, 36:1960-1967.
5. Chen K., Bandy D., Reiman E., Huang S.C., Lawson M., Feng D., et al. Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J Cereb Blood Flow Metab 1998, 18:716-723.
6. Caselli R.J., Chen K., Bandy D., Smilovici O., Boeve B.F., Osborne D., et al. A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. Sleep 2006, 29:927-933.
7. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci U S A 2004, 101:284-289.
8. Lopresti B.J., Klunk W.E., Mathis C.A., Hoge J.A., Ziolko S.K., Lu X., et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 2005, 46:1959-1972.
9. Zanotti-Fregonara P., Liow J.S., Fujita M., Dusch E., Zoghbi S.S., Luong E., et al. Image-derived input function for human brain using high resolution PET imaging with [C](R)-rolipram and [C]PBR28. PLoS One 2011, 6:e17056.
10. Pike V.W., McCarron J.A., Lammertsma A.A., Osman S., Hume S.P., Sargent P.A., et al. Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. Eur J Pharmacol 1996, 301:R5-R7.
11. Fisher P.M., Meltzer C.C., Ziolko S.K., Price J.C., Moses-Kolko E.L., Berga S.L., et al. Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat Neurosci 2006, 9:1362-1363.
12. Hahn A., Wadsak W., Windischberger C., Baldinger P., Hoflich A.S., Losak J., et al. Differential modulation of the default mode network via serotonin-1A receptors. Proc Natl Acad Sci U S A 2012, 109:2619-2624.
13. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999, 46:1375-1387.
14. Hirvonen J., Karlsson H., Kajander J., Lepola A., Markkula J., Rasi-Hakala H., et al. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 2008, 11:465-476.
15. Parsey R.V., Ogden R.T., Miller J.M., Tin A., Hesselgrave N., Goldstein E., et al. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry 2010, 68:170-178.
16. Sullivan G.M., Ogden R.T., Oquendo M.A., Kumar J.S., Simpson N., Huang Y.Y., et al. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biol Psychiatry 2009, 66:223-230.
17. Sargent P.A., Rabiner E.A., Bhagwagar Z., Clark L., Cowen P., Goodwin G.M., et al. 5-HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-(11)C]WAY-100635. J Affect Disord 2010, 123:77-80.
18. Lanzenberger R.R., Mitterhauser M., Spindelegger C., Wadsak W., Klein N., Mien L.-K., et al. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 2007, 61:1081-1089.
19. Nash J.R., Sargent P.A., Rabiner E.A., Hood S.D., Argyropoulos S.V., Potokar J.P., et al. Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br J Psychiatry 2008, 193:229-234.
20. Bailer U.F., Bloss C.S., Frank G.K., Price J.C., Meltzer C.C., Mathis C.A., et al. 5-HTA receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups. Int J Eat Disord 2011, 44:477-487.
21. van Velden F.H., Kloet R.W., van Berckel B.N., Buijs F.L., Luurtsema G., Lammertsma A.A., et al. HRRT versus HR+human brain PET studies: an interscanner test-retest study. J Nucl Med 2009, 50:693-702.
22. Varrone A., Sjoholm N., Eriksson L., Gulyas B., Halldin C., Farde L. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur J Nucl Med Mol Imaging 2009, 36:1639-1650.
23. Schain M., Toth M., Cselenyi Z., Stenkrona P., Halldin C., Farde L., et al. Quantification of serotonin transporter availability with [11C]MADAM-a comparison between the ECAT HRRT and HR systems. Neuroimage 2012, 60:800-807.
24. Fung E.K., Planeta-Wilson B., Mulnix T., Carson R.E. A multimodal approach to image-derived input functions for brain PET. IEEE Nucl Sci Symp Conf Rec 1997, 2009:2710-2714.
25. Mourik J.E., van Velden F.H., Lubberink M., Kloet R.W., van Berckel B.N., Lammertsma A.A., et al. Image derived input functions for dynamic high resolution research tomograph PET brain studies. Neuroimage 2008, 43:676-686.
26. Hahn A., Nics L., Baldinger P., Ungersboeck J., Dolliner P., Frey R., et al. Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial blood sampling. Neuro Image 2012, 62:199-206.
27. Lanzenberger R., Baldinger P., Hahn A., Ungersboeck J., Mitterhauser M., Winkler D., et al. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol Psychiatry 2013, 18:93-100.
28. Bauer M., Bschor T., Pfennig A., Whybrow P.C., Angst J., Versiani M., et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007, 8:67-104.
29. Wadsak W., Mien L.K., Ettlinger D.E., Lanzenberger R., Haeusler D., Dudczak R., et al. Simple and fully automated preparation of [carbonyl-11C]WAY-100635. Radiochimica Acta 2007, 95:417-422.
30. Casey M. Point spread function reconstruction in PET. Siemens Mol Imaging 2007.
31. Nics L., Hahn A., Zeilinger M., Vraka C., Ungersboeck J., Haeusler D., et al. Quantification of the radio metabolites of the serotonin-1A receptor radioligand [carbonyl-11C]WAY-100635 in human plasma: an HPLC-assay allowing two parallel patients. Appl Radiat Isotopes 2012, 70:2730-2736.
32. Gunn R.N., Sargent P.A., Bench C.J., Rabiner E.A., Osman S., Pike V.W., et al. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 1998, 8:426-440.
33. Rousset O.G., Ma Y., Evans A.C. Correction for partial volume effects in PET: principle and validation. J Nucl Med 1998, 39:904-911.
34. Stein P., Savli M., Wadsak W., Mitterhauser M., Fink M., Spindelegger C., et al. The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur J Nucl Med Mol Imaging 2008, 35:2159-2168.
35. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007, 27:1533-1539.
36. Hirvonen J., Kajander J., Allonen T., Oikonen V., Nagren K., Hietala J. Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region. J Cereb Blood Flow Metab 2007, 27:185-195.
37. Ichise M., Liow J.S., Lu J.Q., Takano A., Model K., Toyama H., et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003, 23:1096-1112.
38. Hahn A., Lanzenberger R., Wadsak W., Spindelegger C., Moser U., Mien L.-K., et al. Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders. J Neurosci 2010, 30:14482-14489.
39. Ogden R.T., Zanderigo F., Choy S., Mann J.J., Parsey R.V. Simultaneous estimation of input functions: an empirical study. J Cereb Blood Flow Metab 2010, 30:816-826.
40. Parsey R., Slifstein M., Hwang D.R., Abi-Dargham A., Simpson N., Mawlawi O., et al. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions. J Cereb Blood Flow Metab 2000, 20:1111-1133.
41. Knausl B., Hirtl A., Dobrozemsky G., Bergmann H., Kletter K., Dudczak R., et al. PET based volume segmentation with emphasis on the iterative TrueX algorithm. Z Med Phys 2012, 22:29-39.
42. Mourik J.E., Lubberink M., Klumpers U.M., Comans E.F., Lammertsma A.A., Boellaard R. Partial volume corrected image derived input functions for dynamic PET brain studies: methodology and validation for [11C]flumazenil. Neuroimage 2008, 39:1041-1050.
43. Zanotti-Fregonara P., Maroy R., Peyronneau M.A., Trebossen R., Bottlaender M. Minimally invasive input function for 2-(18)F-fluoro-A-85380 brain PET studies. Eur J Nucl Med Mol Imaging 2012, 39:651-659.